Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Haematologica|December 18, 2009
Myelin protein zero is naturally processed in the B cells of monoclonal gammopathy of undetermined significance of immunoglobulin M isotype: aberrant triggering of a patient's T cellsEva Hellqvist, Maria Kvarnström, Anita Söderberg, et al.
Contrast Media & Molecular Imaging|June 12, 2008
Positive MRI contrast enhancement in THP-1 cells with Gd2O3 nanoparticlesAnna Klasson, Maria Ahrén, Eva Hellqvist, et al.
Acta Haematologica|February 25, 2021
Burden of Treatment-Induced Peripheral Neuropathy in Patients with Multiple Myeloma in SwedenHareth Nahi, Göran Walinder, Vishal Patel, et al.
Blood|January 29, 2008
A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodiesAnna Lanemo Myhrinder, Eva Hellqvist, Ekaterina Sidorova, et al.
Clinical Hematology International|December 29, 2025
Real-world outcomes in patients with relapsed and refractory multiple myeloma with prior proteasome inhibitor and lenalidomide exposure: A single-center study in SwedenVincent Luong, Muhammad Kashif, Katarina Uttervall, et al.
Oncoimmunology|June 22, 2012
Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infectionAnders Rosén, Ann-Charlotte Bergh, Peter Gogok, et al.
Blood|March 10, 2018
Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myelomaYi Jin, Kenian Chen, Ayla De Paepe, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 26, 2023
Patient Confidence and Information Preferences During the Treatment Decision-making Process: Results From a Large Multiple Myeloma Patient Survey Across 12 Countries in Europe and IsraelUlf-Henrik Mellqvist, H Tilman Steinmetz, Aurore Perrot, et al.
Leukemia & Lymphoma|January 10, 2013
Molecular characterization of neoplastic and normal "sister" lymphoblastoid B-cell lines from chronic lymphocytic leukemiaAnna Lanemo Myhrinder, Eva Hellqvist, Ann-Charlotte Bergh, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2015
Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewalFrida Holm, Eva Hellqvist, Cayla N Mason, et al.
Pageof 2